Tadalafil
- Product NDC
- 71610-298
- Requested package NDC
- 71610-298-47
- 11-digit product format
- 716100298
- Labeler code
- 71610
- Product ID
- 71610-298_6900b36a-1103-4d04-a5b6-89a1637958ee
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Tadalafil
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- Aphena Pharma Solutions - Tennessee, LLC
- Application
- ANDA209908
- Marketing category
- ANDA
- Marketing start
- 2019-03-26
- Marketing end
- 0000-00-00
- Substance
- TADALAFIL
- Active strength
- 5 mg/1
- Pharmacologic classes
- Phosphodiesterase 5 Inhibitor [EPC],Phosphodiesterase 5 Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2020-12-31
- Current FDA listing
- Historical FDA.report record
NDC auxiliary status#
Explicit status records from FDA unfinished, excluded, and compounder auxiliary files. Absence of a row is not itself a regulatory status. Browse every current auxiliary row, including rows without a usable NDC. · Browse every captured source and parsed snapshot.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded package | package | 71610-298 | 71610-298-47 | I | Inactivated by FDA | 2026-07-31 |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A209908-001 | TADALAFIL | TADALAFIL | 2.5MG | TABLET / ORAL | AB1 | 2019-03-26 | |
| A209908-002 | TADALAFIL | TADALAFIL | 5MG | TABLET / ORAL | AB1 | 2019-03-26 | |
| A209908-003 | TADALAFIL | TADALAFIL | 10MG | TABLET / ORAL | AB1 | 2019-03-26 | |
| A209908-004 | TADALAFIL | TADALAFIL | 20MG | TABLET / ORAL | AB1 | 2019-03-26 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A209908-001 | AB1 |
| A209908-002 | AB1 |
| A209908-003 | AB1 |
| A209908-004 | AB1 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A209908-001 | TADALAFIL | 2.5MG | TABLET / ORAL | AB1 | 2019-03-26 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | A209908-002 | TADALAFIL | 5MG | TABLET / ORAL | AB1 | 2019-03-26 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | A209908-003 | TADALAFIL | 10MG | TABLET / ORAL | AB1 | 2019-03-26 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | A209908-004 | TADALAFIL | 20MG | TABLET / ORAL | AB1 | 2019-03-26 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A209908-001 | AB1 | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A209908-002 | AB1 | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A209908-003 | AB1 | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A209908-004 | AB1 | 1 | a50c72e98297… |
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Tadalafil | TADALAFIL | NuCare Pharmaceutical,Inc. | 48850075-ac57-abb7-e063-6394a90a7881 | 2026-01-16 | Warnings, Adverse reactions | 209908 ANDA209908 |
| Tadalafil | TADALAFIL | NuCare Pharmaceuticals, Inc. | 48892acb-43bb-a4d8-e063-6394a90a5d61 | 2026-01-16 | Warnings, Adverse reactions | 209908 ANDA209908 |
| Tadalafil | TADALAFIL | XLCare Pharmaceuticals Inc. | add6afb8-d38c-47a2-8c35-d5940667bb0c | 2024-12-09 | Warnings, Adverse reactions | 209908 ANDA209908 |
| Tadalafil | TADALAFIL | A-S Medication Solutions | b9d71483-861b-465b-846b-d7bfd6cbac11 | 2023-12-26 | Warnings, Adverse reactions | 209908 ANDA209908 |
| Tadalafil | TADALAFIL | A-S Medication Solutions | c1c8feb4-a85a-4f39-8c44-bc9cd77226f4 | 2023-12-21 | Warnings, Adverse reactions | 209908 ANDA209908 |
| Tadalafil | TADALAFIL | Camber Pharmaceuticals, Inc. | a3892605-4eb1-4d6e-a675-f7f7d4302f38 | 2019-03-26 | Warnings, Adverse reactions | 209908 ANDA209908 |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| b90b74cb-f6c8-3798-d11c-73b8768b278a | Product name | 8 | 20250317 |
| 0fe0157c-95a7-4870-ae64-de9f3fa874ae | Product name | 1 | 20250227 |
| 20ae0006-d78c-4dba-9e3e-6ae424841903 | Product name | 1 | 20250127 |
| b86a08b7-54cc-440b-ad4a-3e530ccd8324 | Product name | 6 | 20230421 |
| 7a02e74a-2844-42af-84a8-96bae57351cf | Product name | 1 | 20230313 |
| 928d249c-35c3-4d88-a9ef-cf2f2e31b96f | Product name | 1 | 20220706 |
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 71610-298-08 | Tadalafil | 8 in 1 BOTTLE | TABLET, FILM COATED | 8 | 1 | |
| 71610-298-11 | Tadalafil | 48 in 1 BOTTLE | TABLET, FILM COATED | 48 | 1 | |
| 71610-298-23 | Tadalafil | 16 in 1 BOTTLE | TABLET, FILM COATED | 16 | 1 | |
| 71610-298-47 | Tadalafil | 24 in 1 BOTTLE | TABLET, FILM COATED | 24 | 1 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 71610-298-08 | EA - Each | 71610-298 | 1a1bdf0b-c7cb-4ad5-a48b-7bb635b96959 | 1 | 2019-08-06 |
| 71610-298-11 | EA - Each | 71610-298 | 49ebfd39-df77-406c-b0a0-d3194736e816 | 1 | 2019-08-06 |
| 71610-298-23 | EA - Each | 71610-298 | 8c3c0a7e-a2fd-4c0e-9d96-f48e12ccc784 | 1 | 2019-08-06 |
| 71610-298-47 | EA - Each | 71610-298 | 0dcf771c-a0bb-468e-9673-5f3a4e617d9f | 1 | 2019-08-06 |
DailyMed Dashboard NDC Coverage#
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 403957 | tadalafil 5 MG Oral Tablet | PSN | 3dd48d6b-2335-4f50-8760-fb1a8bf226c0 | 1 |
| 403957 | tadalafil 5 MG Oral Tablet | SCD | 3dd48d6b-2335-4f50-8760-fb1a8bf226c0 | 1 |
Packages#
| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 71610-298-47 | 71610029847 | 24 TABLET, FILM COATED in 1 BOTTLE (71610-298-47) | 2019-07-01 | 0000-00-00 | No | No | Current |